On August 18, 2026, Anthropic announced it selected Twist Bioscience as an independent evaluator to rapidly produce at scale AI-designed proteins for a multi-arm campaign against 15 targets using Claude Opus 4.8 and Mythos Preview. This partnership involves testing designs for binding capabilities. The company operates in the synthetic biology industry, specializing in DNA synthesis and protein design.
